首页 正文

Review Hepatology forum. 2022 Apr 26;3(2):68-70. doi: 10.14744/hf.2022.2022.0012 Q32.12025

Coronavirus disease 2019 (COVID-19) in autoimmune hepatitis

新型冠状病毒肺炎(COVID-19)与自身免疫性肝炎 翻译改进

Seyda Nur Dagli  1, Cumali Efe  2

作者单位 +展开

作者单位

  • 1 Department of Physiology, Harran University Faculty of Medicine, Sanliurfa, Turkey.
  • 2 Department of Gastroenterology, Harran University Faculty of Medicine, Sanliurfa, Turkey.
  • DOI: 10.14744/hf.2022.2022.0012 PMID: 35783480

    摘要 Ai翻译

    Severe acute respiratory syndrome coronavirus 2 is a highly transmissible and pathogenic virus that leads to coronavirus disease 2019 (COVID-19). The preexisting liver diseases alter the course of COVID-19. Therefore, specific management strategies must be considered in individuals with chronic liver diseases (CLDs) and COVID-19. Autoimmune hepatitis (AIH) is a rare immune-mediated liver disease. Patients with AIH require life-long treatment with immunosup... ...点击完成人机验证后继续浏览
    Copyright © Hepatology forum. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Hepatology forum

    缩写:HEPATOL FORUM

    ISSN:1307-5888

    e-ISSN:2757-7392

    IF/分区:2.1/Q3

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Coronavirus disease 2019 (COVID-19) in autoimmune hepatitis